Hildy Dillon

1.3k total citations
23 papers, 903 citations indexed

About

Hildy Dillon is a scholar working on Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Hildy Dillon has authored 23 papers receiving a total of 903 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 9 papers in Pathology and Forensic Medicine and 5 papers in Genetics. Recurrent topics in Hildy Dillon's work include Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Ethics in Clinical Research (5 papers). Hildy Dillon is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Acute Lymphoblastic Leukemia research (6 papers) and Ethics in Clinical Research (5 papers). Hildy Dillon collaborates with scholars based in United States, Canada and India. Hildy Dillon's co-authors include John P. Leonard, Janet Z. Yang, Geri Gay, Katherine A. McComas, Andrew J. Dannenberg, Mark Walker, Kenita S. Rogers, Jonathan W. Friedberg, Andrew D. Zelenetz and Brian K. Link and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

Hildy Dillon

23 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hildy Dillon United States	14	337	321	252	196	148	23	903
Julie Wolfson United States	16	191 0.6×	270 0.8×	269 1.1×	114 0.6×	82 0.6×	57	1.2k
TA Lister United Kingdom	19	532 1.6×	405 1.3×	175 0.7×	116 0.6×	42 0.3×	32	1.0k
Robert Sage Australia	21	263 0.8×	568 1.8×	90 0.4×	454 2.3×	116 0.8×	68	1.8k
Thomas Haas United States	14	71 0.2×	199 0.6×	160 0.6×	103 0.5×	46 0.3×	30	1.1k
Ping Tu China	21	297 0.9×	189 0.6×	333 1.3×	31 0.2×	192 1.3×	109	1.7k
Eva M. Lepisto United States	12	240 0.7×	365 1.1×	121 0.5×	18 0.1×	174 1.2×	28	1.0k
Dorothy L. Williams United States	18	173 0.5×	210 0.7×	727 2.9×	801 4.1×	45 0.3×	36	1.6k
Fuat Oduncu Germany	23	119 0.4×	643 2.0×	160 0.6×	230 1.2×	15 0.1×	74	1.5k
J. Slack United Kingdom	14	373 1.1×	311 1.0×	79 0.3×	137 0.7×	24 0.2×	28	1.0k
Lauren Harrison United States	24	530 1.6×	512 1.6×	323 1.3×	444 2.3×	153 1.0×	83	1.5k

Countries citing papers authored by Hildy Dillon

Since Specialization

Citations

This map shows the geographic impact of Hildy Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hildy Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hildy Dillon more than expected).

Fields of papers citing papers by Hildy Dillon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hildy Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hildy Dillon. The network helps show where Hildy Dillon may publish in the future.

Co-authorship network of co-authors of Hildy Dillon

This figure shows the co-authorship network connecting the top 25 collaborators of Hildy Dillon. A scholar is included among the top collaborators of Hildy Dillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hildy Dillon. Hildy Dillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brém, Elizabeth, Hongli Li, Anne Beaven, et al.. (2021). SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool. Journal of Geriatric Oncology. 13(2). 258–264. 12 indexed citations

Zaleta, Alexandra K., Shauna McManus, M. F. Miller, et al.. (2019). Cancer-Related Distress and Unmet Needs Among Acute Myeloid Leukemia Survivors. Blood. 134(Supplement_1). 4787–4787. 1 indexed citations

Nooka, Ajay K., Chadi Nabhan, Xiaolei Zhou, et al.. (2012). Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices. Annals of Oncology. 24(2). 441–448. 69 indexed citations

Yang, Janet Z., Katherine A. McComas, Geri Gay, et al.. (2012). Comparing Decision Making Between Cancer Patients and the General Population: Thoughts, Emotions, or Social Influence?. Journal of Health Communication. 17(4). 477–494. 13 indexed citations

Oliansky, Denise M, Bruce M. Camitta, Paul S. Gaynon, et al.. (2011). Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review. Biology of Blood and Marrow Transplantation. 18(4). 505–522. 77 indexed citations

Oliansky, Denise M, Richard A. Larson, Daniel J. Weisdorf, et al.. (2011). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review. Biology of Blood and Marrow Transplantation. 18(1). 18–36.e6. 32 indexed citations

Link, Brian K., Thomas P. Miller, Michelle Byrtek, et al.. (2011). Second-line therapy in follicular lymphoma in the United States: Report of NLCS observational study.. Journal of Clinical Oncology. 29(15_suppl). 8049–8049. 3 indexed citations

McComas, Katherine A., Janet Z. Yang, Geri Gay, et al.. (2010). Individuals' Willingness to Talk to Their Doctors About Clinical Trial Enrollment. Journal of Health Communication. 15(2). 189–204. 28 indexed citations

Yang, Janet Z., Katherine A. McComas, Geri Gay, et al.. (2010). Motivation for Health Information Seeking and Processing About Clinical Trial Enrollment. Health Communication. 25(5). 423–436. 80 indexed citations

10.

Taylor, Meghan M., Hildy Dillon, Andrew D. Zelenetz, et al.. (2010). Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL).. Journal of Clinical Oncology. 28(15_suppl). 8100–8100. 2 indexed citations

11.

Flowers, Christopher R., Michael Taylor, Michelle Byrtek, et al.. (2010). Does An Anthracycline Make a Difference for Follicular Lymphoma (FL) Grade 3? Patterns of Care and Treatment Outcomes of Grade 3 FL From the National LymphoCare Study (NLCS). Blood. 116(21). 1768–1768. 1 indexed citations

12.

Yang, Janet Z., et al.. (2010). Applying the theory of planned behavior to study health decisions related to potential risks. Journal of Risk Research. 13(8). 1007–1026. 20 indexed citations

13.

Yang, Janet Z., Katherine A. McComas, Geri Gay, et al.. (2009). From information processing to behavioral intentions: Exploring cancer patients’ motivations for clinical trial enrollment. Patient Education and Counseling. 79(2). 231–238. 49 indexed citations

14.

McComas, Katherine A., et al.. (2008). Talking to Doctors About Clinical Trials. 1–26. 1 indexed citations

15.

Friedberg, Jonathan W., et al.. (2007). Characteristics of Patients with Stage I Follicular Lymphoma (FL) Selected for Watchful Waiting (WW) in the US: Report from the National LymphoCare Study (NLCS).. Blood. 110(11). 3315–3315. 1 indexed citations

16.

Hahn, Theresa, Donna A. Wall, Bruce M. Camitta, et al.. (2006). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Adults: An Evidence-based Review. Biology of Blood and Marrow Transplantation. 12(1). 1–30. 77 indexed citations

17.

Friedberg, Jonathan W., Jie Huang, Hildy Dillon, et al.. (2006). Initial therapeutic strategy in follicular lymphoma (FL): An analysis from the National LymphoCare Study (NLCS). Journal of Clinical Oncology. 24(18_suppl). 7527–7527. 23 indexed citations

18.

Hahn, Theresa, Donna A. Wall, Bruce M. Camitta, et al.. (2005). The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Therapy of Acute Lymphoblastic Leukemia in Children: An Evidence-Based Review. Biology of Blood and Marrow Transplantation. 11(11). 823–861. 48 indexed citations

19.

Link, Brian K., James R. Cerhan, Hildy Dillon, et al.. (2005). Prospective Validation of the FLIPI: Baseline Distribution and Correlates in Newly Diagnosed Follicular Lymphoma (FL) Patients from the US: First Report of the National LymphoCare Study.. Blood. 106(11). 1000–1000. 1 indexed citations

20.

Rogers, Kenita S., Mark Walker, & Hildy Dillon. (1998). Transmissible venereal tumor: a retrospective study of 29 cases. Journal of the American Animal Hospital Association. 34(6). 463–470. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact